몰타 - 영어 - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - powder for solution for infusion or injection - cefuroxime sodium 750 mg - antibacterials for systemic use

몰타 - 영어 - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - powder for solution for infusion or injection - cefuroxime sodium 1500 mci - antibacterials for systemic use

몰타 - 영어 - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - powder for solution for infusion or injection - cefuroxime sodium 750 mg - antibacterials for systemic use

몰타 - 영어 - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - powder for solution for infusion or injection - ceftriaxone sodium 1500 mg - antibacterials for systemic use

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - cefuroxime axetil - film coated tablet - 125 base milligrams

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - cefuroxime axetil - film coated tablet - 500 base milligrams

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - cefuroxime axetil - film coated tablet - 250 base milligrams

미국 - 영어 - NLM (National Library of Medicine)

preferred pharmaceuticali inc. - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 500 mg - cefuroxime axetil tablets usp are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes . limitations of use cefuroxime axetil tablets usp are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae, haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets usp are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute bacterial maxillary sinusitis caused by susceptible strains of streptococcus pneumoniae or haemophilus influenzae (non- β-lactamase–producing strains only). limitations of use the effectiveness of cefuroxime axetil tablets usp for sinus infections caused by β-la

미국 - 영어 - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 250 mg - cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes. limitations of use cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae , haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute bacterial maxillary sinusitis caused by susceptible strains of streptococcus pneumoniae or haemophilus influenzae (non-β-lactamase–producing strains only). limitations of use the effectiveness of cefuroxime axetil for sinus infections caused by β-lactamase–producing haemoph

미국 - 영어 - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 250 mg - cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes . limitations of use - the efficacy of cefuroxime axetil tablets in the prevention of rheumatic fever was not established in clinical trials. - the efficacy of cefuroxime axetil tablets in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae, haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-mode